These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10771663)

  • 1. [Function of adenosine receptors in the central nervous system].
    Kuwana Y
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):991-5. PubMed ID: 10771663
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of adenosine in the central nervous system].
    Zhang WL; Lu GW
    Sheng Li Ke Xue Jin Zhan; 1996 Oct; 27(4):313-8. PubMed ID: 9772380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between adenosine and opioid receptors.
    Peart JN; Gross GJ
    Drug News Perspect; 2005 May; 18(4):237-42. PubMed ID: 16034479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal of a guanine-based purinergic system in the mammalian central nervous system.
    Schmidt AP; Lara DR; Souza DO
    Pharmacol Ther; 2007 Dec; 116(3):401-16. PubMed ID: 17884172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for adenosine A3 receptors.
    Ribeiro JA; Sebastião AM
    Trends Pharmacol Sci; 1994 Jan; 15(1):13; author reply 14. PubMed ID: 8140651
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.
    Stone TW; Ceruti S; Abbracchio MP
    Handb Exp Pharmacol; 2009; (193):535-87. PubMed ID: 19639293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain.
    Giménez-Llort L; Schiffmann SN; Shmidt T; Canela L; Camón L; Wassholm M; Canals M; Terasmaa A; Fernández-Teruel A; Tobeña A; Popova E; Ferré S; Agnati L; Ciruela F; Martínez E; Scheel-Kruger J; Lluis C; Franco R; Fuxe K; Bader M
    Neurobiol Learn Mem; 2007 Jan; 87(1):42-56. PubMed ID: 16824773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A3 receptors: two into one won't go.
    Carruthers AM; Fozard JR
    Trends Pharmacol Sci; 1993 Aug; 14(8):290-1. PubMed ID: 8249145
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adenosine--neurotransmitter and neuromodulator in the central nervous system].
    Romanowska M; Komoszyński M
    Postepy Biochem; 2002; 48(3):230-8. PubMed ID: 12625251
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.
    Fuxe K; Ferré S; Genedani S; Franco R; Agnati LF
    Physiol Behav; 2007 Sep; 92(1-2):210-7. PubMed ID: 17572452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of adenosine on the fetus and newborn.
    Rivkees SA; Zhao Z; Porter G; Turner C
    Mol Genet Metab; 2001; 74(1-2):160-71. PubMed ID: 11592813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adenosine as a modulator of synaptic activity in the central nervous system.
    Brundege JM; Dunwiddie TV
    Adv Pharmacol; 1997; 39():353-91. PubMed ID: 9160120
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenosine and brain function.
    Fredholm BB; Chen JF; Cunha RA; Svenningsson P; Vaugeois JM
    Int Rev Neurobiol; 2005; 63():191-270. PubMed ID: 15797469
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacology; 2007; 79(3):171-83. PubMed ID: 17377417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strategy for development of imaging biomarkers].
    Ishiwata K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of methylmercury on motor activity are sex- and age-dependent, and modulated by genetic deletion of adenosine receptors and caffeine administration.
    Björklund O; Kahlström J; Salmi P; Ogren SO; Vahter M; Chen JF; Fredholm BB; Daré E
    Toxicology; 2007 Nov; 241(3):119-33. PubMed ID: 17920182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic dysfunction in mania: an integrative model.
    Machado-Vieira R; Lara DR; Souza DO; Kapczinski F
    Med Hypotheses; 2002 Apr; 58(4):297-304. PubMed ID: 12027524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats.
    Abou-Donia MB; Abdel-Rahman A; Goldstein LB; Dechkovskaia AM; Shah DU; Bullman SL; Khan WA
    Arch Toxicol; 2003 Aug; 77(8):452-8. PubMed ID: 12937891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.